Werewolf Therapeutics (HOWL) Other Accumulated Expenses (2021 - 2023)

Werewolf Therapeutics has reported Other Accumulated Expenses for 3 years, with the latest figure at $1.6 million in Q2 2023.

• Other Accumulated Expenses for Q2 2023 came in at $1.6 million, down 86.41% year-over-year; the trailing twelve-month figure through Jun 2023 was $1.6 million (down 86.41% YoY), and the FY2022 annual result was $6.5 million, changed N/A from the prior year.
• Other Accumulated Expenses declined to $1.6 million in Q2 2023, from $4.1 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $11.8 million in Q2 2022 and troughed at $20000.0 in Q1 2021.
• A 3-year average of $5.8 million and a median of $5.3 million in 2022 frame the typical range for Other Accumulated Expenses.
• The largest YoY upside for Other Accumulated Expenses was 86.41% in 2023 against a maximum downside of 86.41% in 2023.
• A 3-year view of Other Accumulated Expenses shows it stood at $20000.0 in 2021, then surged by 32560.0% to $6.5 million in 2022, then sank by 75.41% to $1.6 million in 2023.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.6 million in Q2 2023, $4.1 million in Q1 2023, and $6.5 million in Q4 2022.